Marathon Asset Management Ltd Raises Stock Position in Teleflex Incorporated $TFX

Marathon Asset Management Ltd lifted its position in Teleflex Incorporated (NYSE:TFX) by 58.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 102,894 shares of the medical technology company’s stock after buying an additional 38,107 shares during the period. Marathon Asset Management Ltd owned approximately 0.23% of Teleflex worth $12,557,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Banque Cantonale Vaudoise grew its position in shares of Teleflex by 82.5% in the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after buying an additional 113 shares during the last quarter. Fifth Third Bancorp grew its position in shares of Teleflex by 7.8% in the 3rd quarter. Fifth Third Bancorp now owns 2,083 shares of the medical technology company’s stock worth $255,000 after buying an additional 151 shares during the last quarter. Oregon Public Employees Retirement Fund grew its position in shares of Teleflex by 1.7% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 10,114 shares of the medical technology company’s stock worth $1,234,000 after buying an additional 167 shares during the last quarter. Osaic Holdings Inc. grew its position in shares of Teleflex by 17.5% in the 2nd quarter. Osaic Holdings Inc. now owns 1,247 shares of the medical technology company’s stock worth $148,000 after buying an additional 186 shares during the last quarter. Finally, Hantz Financial Services Inc. grew its position in shares of Teleflex by 248.8% in the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after buying an additional 199 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on TFX shares. Truist Financial reaffirmed a “hold” rating and issued a $143.00 price objective (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. Mizuho set a $140.00 target price on shares of Teleflex in a research report on Friday, May 8th. Needham & Company LLC boosted their target price on shares of Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research report on Thursday, February 26th. Bank of America raised shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price on the stock in a research report on Monday, April 13th. Finally, Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Three investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $144.00.

Teleflex Stock Up 2.0%

NYSE:TFX opened at $133.01 on Wednesday. The company has a market cap of $5.89 billion, a PE ratio of -5.83, a P/E/G ratio of 0.97 and a beta of 0.82. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $139.67. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. The company’s 50 day moving average is $121.39 and its two-hundred day moving average is $116.69.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.21 by $0.18. The business had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business’s quarterly revenue was up 32.3% compared to the same quarter last year. During the same period in the previous year, the business posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Analysts anticipate that Teleflex Incorporated will post 6.7 EPS for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, May 22nd. Teleflex’s dividend payout ratio is -5.96%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.